The SOT Annual Meeting is the forum to showcase toxicology’s novel discoveries. For the science of toxicology, this five-day event is the culmination of a year’s worth of achievements in research and education. The Annual Meeting also affords attendees the opportunity to learn about the latest scientific achievements from myriad experts in the field of toxicology. The SOT thematic program provides participants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. Opportunities abound for members to meet other scientists they have never met and to network with friends and colleagues. The Annual Meeting also offers a chance to pause and pay tribute to those scientists who have distinguished themselves in their field of expertise and are the recipients of the Society's most prestigious awards. Finally, SOT attendees can take advantage of the ToxExpo, which is the world’s largest exposition of its kind, offering a comprehensive marketplace for product information and cutting-edge technology.
MedImmune will present "Alternative Approach for Nonclinical Safety Assessment of a novel bispecific single-chain BiTE Antibody" and "Nonclinical safety evaluation of MEDI-573, a dual-targeting anti-insulin-like growth factor (IGF)-I and IGF-II monoclonal antibody in cynomolgus monkeys."
Added by MedImmune on February 3, 2012